Quoin Pharmaceuticals
QNRX
10 hedge funds and large institutions have $128K invested in Quoin Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
25% more funds holding
Funds holding: 8 → 10 (+2)
0.01% more ownership
Funds ownership: 0.15% → 0.16% (+0.01%)
30% less capital invested
Capital invested by funds: $183K → $128K (-$55.5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$26.8K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$17K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.2K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$7.98K |
| 5 |
Two Sigma Investments
New York
|
+$7.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$29K |
| 2 |
HF
HRT Financial
New York
|
-$28K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$10.2K |
| 4 |
Renaissance Technologies
New York
|
-$8.94K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
Altium Capital Management
New York
| $59.8K | +$26.8K | +1,053 | +56% |
|
|
2
Renaissance Technologies
New York
| $19.8K | -$8.94K | -352 | -26% |
|
|
TSS
3
Two Sigma Securities
New York
| $13.6K | +$17K | +670 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $8.97K | +$11.2K | +441 | New |
|
|
5
RhumbLine Advisers
Boston,
Massachusetts
| $8.59K | +$7.98K | +314 | +288% |
|
|
6
Two Sigma Investments
New York
| $6.33K | +$7.93K | +312 | New |
|
|
OIA
7
OneDigital Investment Advisors
Overland Park,
Kansas
| $6.03K | +$7.54K | +297 | New |
|
8
UBS Group
Zurich,
Switzerland
| $3.54K | +$711 | +28 | +19% |
|
9
Bank of America
Charlotte,
North Carolina
| $580 | +$737 | +29 | New |
|
10
JP Morgan Chase
New York
| $375 | – | – | – |
|
|
HNB
11
Huntington National Bank
Columbus,
Ohio
| $6 | – | – | – |
|
|
VF
12
Virtu Financial
New York
| – | -$29K | -879 | Closed |
|
|
HF
13
HRT Financial
New York
| – | -$28K | -866 | Closed |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$10.2K | -308 | Closed |
|
QNRX Hedge Fund Activity: Q2 2024 in Review
10 of the 6,927 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q2 2024, worth a combined $128K — down 30% from $183K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new QNRX positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Altium Capital Management, adding an estimated $26.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $29K sold.
- 10 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q2 2024, up from 8 in Q1 2024.
- Funds reported $128K of Quoin Pharmaceuticals stock for Q2 2024, down 30% quarter-over-quarter.
- 5 funds opened new Quoin Pharmaceuticals positions in Q2 2024 and 3 closed out, a net change of +2 holders.
- The largest Quoin Pharmaceuticals buyer in Q2 2024 was Altium Capital Management, an estimated $26.8K added.
- The largest Quoin Pharmaceuticals seller in Q2 2024 was Virtu Financial, an estimated $29K sold.
Based on aggregated 13F filings for Q2 2024.